ATE540317T1 - Fret-protease-assays für clostridielle toxine - Google Patents

Fret-protease-assays für clostridielle toxine

Info

Publication number
ATE540317T1
ATE540317T1 AT07023843T AT07023843T ATE540317T1 AT E540317 T1 ATE540317 T1 AT E540317T1 AT 07023843 T AT07023843 T AT 07023843T AT 07023843 T AT07023843 T AT 07023843T AT E540317 T1 ATE540317 T1 AT E540317T1
Authority
AT
Austria
Prior art keywords
clostridial toxin
donor fluorophore
acceptor
lanthanide donor
clostridial toxins
Prior art date
Application number
AT07023843T
Other languages
English (en)
Inventor
Lance Steward
Ester Fernandez-Salas
Kei Aoki
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27613894&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE540317(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE540317T1 publication Critical patent/ATE540317T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT07023843T 2001-08-28 2002-08-22 Fret-protease-assays für clostridielle toxine ATE540317T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/942,098 US7332567B2 (en) 2001-08-28 2001-08-28 Fret protease assays for clostridial toxins

Publications (1)

Publication Number Publication Date
ATE540317T1 true ATE540317T1 (de) 2012-01-15

Family

ID=27613894

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07023843T ATE540317T1 (de) 2001-08-28 2002-08-22 Fret-protease-assays für clostridielle toxine
AT02807745T ATE541213T1 (de) 2001-08-28 2002-08-22 Fret-protease-assays für clostridientoxine

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02807745T ATE541213T1 (de) 2001-08-28 2002-08-22 Fret-protease-assays für clostridientoxine

Country Status (9)

Country Link
US (10) US7332567B2 (de)
EP (2) EP1438586B1 (de)
JP (3) JP2005520000A (de)
AT (2) ATE540317T1 (de)
AU (1) AU2002368109B8 (de)
BR (1) BRPI0212140B8 (de)
CA (1) CA2462686C (de)
DK (2) DK1901069T3 (de)
WO (1) WO2004031773A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060141572A1 (en) * 1993-09-21 2006-06-29 Smith Leonard A Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
FR2809733B1 (fr) * 2000-06-02 2004-04-30 Inst Nat Sante Rech Med Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants
US7354735B2 (en) * 2001-05-24 2008-04-08 Hong Kong University Of Science And Technology Nucleic acid encoding fluorescent protein constructs and methods for detecting apoptosis
US20080064054A1 (en) * 2001-08-28 2008-03-13 Ester Fernandez-Salas Fluorescence resonance energy transfer (fret) assays for clostridial toxin activity
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US7208285B2 (en) * 2001-08-28 2007-04-24 Allergan, Inc. Fret protease assays for botulinum serotype A/E toxins
US8022172B2 (en) * 2001-08-28 2011-09-20 Allergan, Inc. Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
US20060063221A1 (en) * 2004-09-21 2006-03-23 Williams Dudley J Lanthanide-based substrates and methods for determining clostridial toxin activity
US7374896B2 (en) * 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
US7183066B2 (en) * 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
AU2003272800A1 (en) * 2002-10-01 2004-04-23 University Of Maryland Methods for identifying inhibitors of botulinum neurotoxins
US20040115727A1 (en) * 2002-12-11 2004-06-17 Allergan, Inc., A Corporation Evolved clostridial toxins with altered protease specificity
CA2550401C (en) 2003-12-19 2015-12-08 Wisconsin Alumni Research Foundation Method and compositions for detecting botulinum neurotoxin
US20080274480A1 (en) * 2004-08-04 2008-11-06 Allergan, Inc. Botulinum Toxin Type a Immunoresistant Assay
WO2006101520A2 (en) * 2004-09-20 2006-09-28 University Of Massachusetts Fluorescent proteins and related methods and compounds
US7399607B2 (en) * 2004-09-22 2008-07-15 Allergan, Inc. Fluorescence polarization assays for determining clostridial toxin activity
EP1824971B1 (de) 2004-11-22 2016-01-13 New York University Genetisch veränderte clostridiengene, durch die veränderten gene kodierte proteine und deren verwendungen
WO2008036060A2 (en) 2005-04-05 2008-03-27 Allergan, Inc. Clostridial toxin activity assays
PT1869459E (pt) * 2005-04-05 2010-08-10 Allergan Inc Ensaios fret à base de corantes lipofílicos para a actividade da toxina de clostrídeo
DE602006013481D1 (de) 2005-09-19 2010-05-20 Allergan Inc Mit clostriedientoxin aktivierbare clostridientoxine
CA2602972C (en) * 2005-10-12 2013-09-24 Allergan, Inc. Assays of molecular or subcellular interactivity using depolarization after resonance energy transfer (daret)
US8753831B2 (en) * 2007-06-05 2014-06-17 City Of Hope Methods for detection of botulinum neurotoxin
CN101932936B (zh) 2007-09-14 2016-04-27 拜奥麦迪逊公司 利用切割序列和间隔子的共振能量转移测定
KR101604515B1 (ko) 2008-03-14 2016-03-17 알러간, 인코포레이티드 면역-기반 보툴리눔 독소 세로타입 ａ 활성 검정
KR101609894B1 (ko) 2008-03-14 2016-04-08 알러간, 인코포레이티드 면역-기반 보툴리눔 독소 세로타입 ａ 활성 검정
RU2535003C2 (ru) 2008-12-10 2014-12-10 Аллерган, Инк. Фармацевтические композиции токсина клостридий
RU2543650C2 (ru) 2009-03-13 2015-03-10 Аллерган, Инк. Иммунологические тесты на активность эндопептидаз с измененной нацеленностью
KR20200146046A (ko) 2009-03-13 2020-12-31 알러간, 인코포레이티드 면역 기반 보툴리눔 독소 혈청형 ａ 활성 검정에 유용한 세포
WO2010124998A1 (en) * 2009-04-27 2010-11-04 Merz Pharma Gmbh & Co. Kgaa Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
EP2483666A1 (de) 2009-10-02 2012-08-08 Allergan, Inc. In-vitro-verfahren zur bestimmung der änderungen in einer proteinumgebung
US9453254B2 (en) * 2009-10-16 2016-09-27 Biomadison, Inc. Resonance energy transfer assay with synaptobrevin substrate moiety
WO2011091419A2 (en) * 2010-01-25 2011-07-28 New York Universiy Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery
US8569254B2 (en) 2010-12-10 2013-10-29 National Yang Ming University Methods for modulating the expression and aggregation of CAG-expanded gene product in cells and methods for identifying agents useful for doing the same
US9217172B2 (en) 2011-09-29 2015-12-22 Cellsnap, Llc Compositions and methods for toxigenicity testing
WO2013102088A2 (en) 2011-12-31 2013-07-04 Allergan, Inc. Highly Sensitive Cell-Based Assay to Detect the Presence of Active Botulinum Neurotoxin Serotype-A
US8962340B2 (en) * 2012-12-03 2015-02-24 Src, Inc. Real-time assay for the detection of botulinum toxin
GB2512691B (en) * 2012-12-03 2016-06-29 Src Inc Real-time assay for the detection of botulinum toxin
EP2943585B1 (de) * 2013-01-09 2018-07-11 Friedrich-Alexander-Universität Erlangen-Nürnberg Verfahren für in-vitro-nachweis und überwachung einer erkrankung durch messung der erkrankungsassoziierten proteaseaktivität in extrazellulären vesikeln
DK2948174T3 (da) 2013-01-28 2019-12-02 Univ New York Fremgangsmåder til behandling under anvendelse af atoksiske neurotoksinderivater
RU2704808C2 (ru) 2013-06-28 2019-10-31 Мерц Фарма Гмбх Энд Ко. Кгаа Средства и способы для определения биологической активности полипептидов нейротоксина в клетках
KR20170026624A (ko) 2014-07-07 2017-03-08 알러간, 인코포레이티드 조직 샘플에서 절단된 snap25를 검출하는 방법
PT3177640T (pt) 2014-08-08 2020-08-31 Univ Leland Stanford Junior Agentes pd-1 de alta afinidade e métodos de utilização
CN107109389A (zh) * 2014-08-12 2017-08-29 拜奥麦迪逊公司 具有修饰的轻链特异性的肉毒杆菌神经毒素及其生产方法
CA2969463A1 (en) 2014-12-09 2016-06-16 New York University Clostridial neurotoxin fusion proteins, propeptide fusions, their expression, and use
CN106117525B (zh) * 2016-06-27 2018-01-05 温州医科大学 pH敏感嵌段聚合物、FRET复合物及其制备方法
AU2017327369A1 (en) 2016-09-13 2019-05-02 Allergan, Inc. Stabilized non-protein Clostridial toxin compositions
WO2018073370A1 (en) * 2016-10-21 2018-04-26 Toxogen Gmbh A functional detection assay devoid of antibodies for serotyping of botulinum neurotoxins
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11499965B2 (en) 2017-02-08 2022-11-15 Tokyo Institute Of Technology Kit for detecting antigen or measuring its amount
GB201702500D0 (en) * 2017-02-16 2017-04-05 Univ Sheffield Stable vamp reporter assay
CN109211863B (zh) * 2018-10-26 2021-04-20 大连民族大学 利用Eu2+f-f跃迁光谱检测爆炸物TNP的方法

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804604A (en) * 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
CA2082770A1 (en) 1992-02-25 1993-08-26 Denis Banville Engineered protein chelates suitable for fluorescent lanthanide (e.g. terbium (iii)) based time resolved fluorescence assays
GB9310978D0 (en) * 1993-05-27 1993-07-14 Zeneca Ltd Compounds
US7214787B1 (en) * 1993-09-21 2007-05-08 United States Of America As Represented By The Secretary Of The Army Recombinant vaccine against botulinum neurotoxin
US7227010B2 (en) * 1993-09-21 2007-06-05 United States Of America As Represented By The Secretary Of The Army Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
GB9411138D0 (en) 1994-06-03 1994-07-27 Microbiological Res Authority Toxin assay
US5962637A (en) 1994-06-03 1999-10-05 Microbiological Research Authority Toxin assay
US5693476A (en) * 1995-02-24 1997-12-02 The Board Of Trustees Of The Leland Stanford Junior University Methods of screening for compounds capable of modulating vesicular release
US5650280A (en) * 1995-03-23 1997-07-22 Incyte Pharmaceuticals, Inc. Cellubrevin homolog
GB9508204D0 (en) 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
US6803188B1 (en) 1996-01-31 2004-10-12 The Regents Of The University Of California Tandem fluorescent protein constructs
WO1997034620A1 (en) * 1996-03-18 1997-09-25 The Regents Of The University Of California Peptide inhibitors of neurotransmitter secretion by neuronal cells
US5965699A (en) * 1996-11-06 1999-10-12 The United States Of America As Represented By The Secretary Of The Army Assay for the proteolytic activity of serotype a from clostridium botulinum
US6197928B1 (en) * 1997-03-14 2001-03-06 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
US6180340B1 (en) 1997-10-31 2001-01-30 Gen-Probe Incorporated Extended dynamic range assays
US6221355B1 (en) * 1997-12-10 2001-04-24 Washington University Anti-pathogen system and methods of use thereof
CA2330560A1 (en) 1998-04-28 1999-11-04 Washington University Methods for transducing fusion molecules
DE69941085D1 (de) * 1998-07-17 2009-08-20 Univ Maryland Manipulierte proteine zum analyten nachweis
WO2000034308A2 (en) 1998-12-10 2000-06-15 Washington University Protein transduction system and methods of use thereof
ES2160485B1 (es) * 1999-04-23 2002-05-16 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
US6713444B1 (en) * 1999-05-14 2004-03-30 The United States Of America As Represented By The Secretary Of The Army Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus neurotoxins
US7235521B1 (en) * 1999-05-17 2007-06-26 United States Of America As Represented By The Secretary Of The Army Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus neurotoxins
US6573244B1 (en) * 1999-05-17 2003-06-03 The United States Of America As Represented By The Secretary Of The Army Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
US6469154B1 (en) * 1999-05-21 2002-10-22 The Regents Of The University Of California Fluorescent protein indicators
CA2379532A1 (en) * 1999-08-20 2001-03-15 Imperial College Innovations Limited Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis
US7740868B2 (en) * 1999-08-25 2010-06-22 Allergan, Inc. Activatable clostridial toxins
ES2277854T5 (es) * 1999-08-25 2011-02-04 Allergan, Inc. Neurotoxinas recombinantes activables.
US7691983B2 (en) * 2000-07-21 2010-04-06 Allergan, Inc. Chimera botulinum toxin type E
US7491799B2 (en) * 2000-07-21 2009-02-17 Allergan, Inc. Modified botulinum neurotoxins
US6903187B1 (en) * 2000-07-21 2005-06-07 Allergan, Inc. Leucine-based motif and clostridial neurotoxins
US20030219462A1 (en) * 2000-07-21 2003-11-27 Allergan Sales, Inc Clostridial neurotoxin compositions and modified clostridial neurotoxins
CA2451909C (en) 2000-09-25 2010-12-21 James J. Schmidt High throughput assays for the proteolytic activities of clostridial neurotoxins
US7273722B2 (en) * 2000-11-29 2007-09-25 Allergan, Inc. Neurotoxins with enhanced target specificity
JP4686906B2 (ja) * 2001-06-04 2011-05-25 株式会社日立製作所 波長多重用光伝送装置
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US20080064054A1 (en) * 2001-08-28 2008-03-13 Ester Fernandez-Salas Fluorescence resonance energy transfer (fret) assays for clostridial toxin activity
US20060063221A1 (en) * 2004-09-21 2006-03-23 Williams Dudley J Lanthanide-based substrates and methods for determining clostridial toxin activity
US8022172B2 (en) * 2001-08-28 2011-09-20 Allergan, Inc. Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
US7374896B2 (en) * 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
US7208285B2 (en) * 2001-08-28 2007-04-24 Allergan, Inc. Fret protease assays for botulinum serotype A/E toxins
US6504006B1 (en) * 2001-10-12 2003-01-07 Nancy Rose Shine Substrate peptides and assays for detecting and measuring proteolytic activity of serotype A neurotoxin from clostridium botulinum
US7183066B2 (en) 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
AU2003272800A1 (en) 2002-10-01 2004-04-23 University Of Maryland Methods for identifying inhibitors of botulinum neurotoxins
US20040115727A1 (en) * 2002-12-11 2004-06-17 Allergan, Inc., A Corporation Evolved clostridial toxins with altered protease specificity
US7611856B2 (en) * 2003-11-05 2009-11-03 Los Alamos National Security, Llc Mass spectrometry-based methods for detection and differentiation of botulinum neurotoxins
CA2550401C (en) * 2003-12-19 2015-12-08 Wisconsin Alumni Research Foundation Method and compositions for detecting botulinum neurotoxin
ATE533853T1 (de) * 2004-02-24 2011-12-15 Allergan Inc Botulinumtoxin-screening-assays
US7514088B2 (en) * 2005-03-15 2009-04-07 Allergan, Inc. Multivalent Clostridial toxin derivatives and methods of their use
US7811584B2 (en) * 2004-06-30 2010-10-12 Allergan, Inc. Multivalent clostridial toxins
US20060024331A1 (en) * 2004-08-02 2006-02-02 Ester Fernandez-Salas Toxin compounds with enhanced membrane translocation characteristics
US7892565B2 (en) * 2004-09-01 2011-02-22 Allergan, Inc. Degradable clostridial toxins
US7399607B2 (en) * 2004-09-22 2008-07-15 Allergan, Inc. Fluorescence polarization assays for determining clostridial toxin activity
PT1869459E (pt) * 2005-04-05 2010-08-10 Allergan Inc Ensaios fret à base de corantes lipofílicos para a actividade da toxina de clostrídeo
WO2008036060A2 (en) * 2005-04-05 2008-03-27 Allergan, Inc. Clostridial toxin activity assays
DE602006013481D1 (de) * 2005-09-19 2010-05-20 Allergan Inc Mit clostriedientoxin aktivierbare clostridientoxine
CA2602972C (en) * 2005-10-12 2013-09-24 Allergan, Inc. Assays of molecular or subcellular interactivity using depolarization after resonance energy transfer (daret)
US8273865B2 (en) * 2006-03-15 2012-09-25 Allergan, Inc. Multivalent clostridial toxins
US7691587B2 (en) * 2006-06-01 2010-04-06 Allergan, Inc. Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides
EP2038298A2 (de) * 2006-07-11 2009-03-25 Allergan, Inc. Modifizierte clostridientoxine mit verbesserten translokationsfähigkeiten und geänderter targeting-aktivität für clostridientoxin-targetzellen
US8067192B2 (en) * 2007-06-05 2011-11-29 City Of Hope Methods for detection of botulinum neurotoxin
AU2010353292A1 (en) * 2009-12-16 2012-07-12 Allergan, Inc. Modified Clostridial toxins comprising an integrated protease cleavage site-binding domain

Also Published As

Publication number Publication date
US20100081158A1 (en) 2010-04-01
JP2005520000A (ja) 2005-07-07
US8048643B2 (en) 2011-11-01
DK1901069T3 (da) 2012-03-12
US20090042231A1 (en) 2009-02-12
EP1901069B1 (de) 2012-01-04
JP2008201786A (ja) 2008-09-04
US8013113B2 (en) 2011-09-06
BRPI0212140B1 (pt) 2014-11-11
BR0212140A (pt) 2007-01-09
US8053208B2 (en) 2011-11-08
US20100075346A1 (en) 2010-03-25
EP1438586A4 (de) 2005-03-16
AU2002368109A1 (en) 2004-04-23
AU2002368109B8 (en) 2008-04-24
US20100075358A1 (en) 2010-03-25
DK1438586T3 (da) 2012-03-19
US20100081157A1 (en) 2010-04-01
AU2002368109B2 (en) 2008-04-03
BRPI0212140B8 (pt) 2021-07-27
US8053209B2 (en) 2011-11-08
US20100151494A1 (en) 2010-06-17
EP1438586B1 (de) 2012-01-11
CA2462686C (en) 2010-07-27
CA2462686A1 (en) 2004-04-15
WO2004031773A1 (en) 2004-04-15
EP1438586A1 (de) 2004-07-21
ATE541213T1 (de) 2012-01-15
US20080032318A1 (en) 2008-02-07
US20030143651A1 (en) 2003-07-31
US20080038756A1 (en) 2008-02-14
US8003753B2 (en) 2011-08-23
US7332567B2 (en) 2008-02-19
EP1901069A1 (de) 2008-03-19
US20100075357A1 (en) 2010-03-25
JP2008174567A (ja) 2008-07-31

Similar Documents

Publication Publication Date Title
ATE540317T1 (de) Fret-protease-assays für clostridielle toxine
WO2003020948A3 (en) Fret protease assays for botulinum serotype a/e toxins
WO2007001358A3 (en) Fluorescence polarization assays for determining clostridial toxin activity
WO2006020748A3 (en) Gfp-snap25 fluorescence release assay for botulinum toxin protease activity
ATE470857T1 (de) Lipophile, farbstoffbasierte fret-assays für die clostridientoxinaktivität
WO2005076785A3 (en) Method and compositions for detecting botulinum neurotoxin
WO2006033843A3 (en) Lanthanide-based substrates and methods for determining clostridial toxin activity
CO5721032A2 (es) Ensayos de transferencia de energia de fluorescencia (fret) basados en celulas para toxinas clostridiales
WO2005007119A3 (en) Assays for protease enzyme activity
WO2002061038A3 (en) Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
ATE532830T1 (de) Langwellige thiolgruppenreaktive fluorophore
DE69528614D1 (de) Modifizierte Proenzyme als Substrate für proteolische Enzyme
AU4701200A (en) A method of detecting an analyte using semiconductor nanocrystals
NO328361B1 (no) Hybridprotein og anvendelse av dette for fremstilling av et medikament for a inhibere mastcelledegranulering
WO2005045392A3 (en) Detection and identification of biopolymers using fluorescence quenching
FR2822847B1 (fr) Milieux de detection specifique de staphylococcus aureus et procede d'identification et/ou de denombrement utilisant de tels milieux
ATE419585T1 (de) System und verfahren zum öffnen und aktivieren von anwendungen, fenstern oder datensätzen auf grundlage von suchkriterien
NO982265L (no) Diagnostikk for og mediatorer for inflammatoriske forstyrrelser
DE60332479D1 (de) Holo-transcobalamin bindungspartner und ihre verwendung in cobalamintest
ES552374A0 (es) Un procedimiento para determinar la actividad de una hidrolasa macromolecular
US20100279328A1 (en) Fret assays, methods for performing the assays and compounds relevant to the assays
BRPI0515397B8 (pt) métodos para detecção e identificação específicas de streptococcus agalactiae usando atividade de esterase, e meio de reação
DE60118350D1 (de) Fluoreszenz-verfahren zum nachweis von proteasen oder peptidasen
AU2003234928A1 (en) Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide
US20240060118A1 (en) Quantum Dot-Peptide PNA-DNA Complexes as a Platform Reporter System for Multiplexed Detection in Cell-Free Transcription Translation-Based Biosensors